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ABSTRACT The slow-channel syndrome (SCS) is a neuromuscular disorder char-
acterized by fatigability, progressive weakness, and degeneration of the neuromuscular
junction. The SCS is caused by missense mutations in the four subunits of the skeletal
muscle acetylcholine receptor (AChR), which leads to altered channel gating, pro-
longed neuromuscular postsynaptic currents, and impaired neuromuscular transmis-
sion. Although a diverse set of mutations in different functional domains of the AChR
appear to be associated with symptoms of widely ranging severity, there is as yet no
mutant channel property or combination that explains the variations in disease sever-
ity. By observing the recovery time of AChR from desensitization, the authors deter-
mined that this process is signiﬁcantly enhanced in SCS channels. In addition, as
expected, the authors found that SCS macroscopic decay currents in transfected
HEK293 cells are slower than wild type currents. While slight differences in relative
Ca
2+ permeability between some SCS mutations were identiﬁed, they did not correlate
with apparent disease severity. These results suggest that of the different AChR
kinetic features studied, only recovery from desensitization and slow postsynaptic cur-
rents correlate with the severity observed in the different mutations of this syndrome.
Synapse 60:441–449, 2006. V V C 2006 Wiley-Liss, Inc.
INTRODUCTION
Nicotinic acetylcholine receptors (AChRs) are ligand-
gated ion channels present in both the nervous system
and muscle. These receptors play a major role in fast syn-
aptic transmission in the CNS and at the neuromuscular
junction (NMJ). In the adult NMJ, AChRs are composed
of four homologous subunits: 2a,1 b,1 d,a n d1 e,e a c ho f
which has four transmembrane domains. Several genetic
disorders resulting from mutations in these ion channel
proteins impair synaptic transmission and lead to neuro-
logical or neuromuscular disease (Bertrand et al., 1998;
Engel et al., 1999). The slow-channel syndrome (SCS) is a
neuromuscular disorder characterized by fatigability, pro-
gressive weakness, and degeneration of the NMJ. The
SCS is caused by missense mutations in the four subunits
of the skeletal muscle AChR (Fig. 1). SCS mutations alter
AChR gating, prolong neuromuscular synaptic currents,
and impair neuromuscular transmission (Croxen et al.,
1997, 2002; Engel et al., 1996; Gomez et al., 1996a,b,
2002b; Milone et al., 1997; Ohno et al., 1995b; Sine et al.,
1995). In all, 15 mutations have been identiﬁed. Most
SCS mutations occur in the pore-forming second trans-
membrane domain (M2), only three mutations have been
found in the ﬁrst transmembrane domain (M1), and two
in the ligand binding domain (Croxen et al., 1997; Engel
et al., 1996; Wang et al., 1997).
Single-channel kinetics studies have determined
that the mutations in SCS change the gating proper-
ties of the channel, leading to increased duration of
channel bursts. These studies have demonstrated that
this change is due to several possible effects on gating
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SYNAPSE 60:441–449 (2006)mechanisms, mainly resulting from a decrease in the
probability of closure of the biliganded channel. This
diverse set of mutations in different functional
domains of the AChR is associated with symptoms of
widely ranging severity. However, a broad panel of dif-
ferent SCS mutations has never been studied system-
atically to ascertain whether any single property or
combination of properties can account for variations in
severity. While the sophisticated methods and models
used to characterize the mutations have provided use-
ful data to gain insight into structural and functional
aspects of the AChR molecule, such kinetic analyses
are sometimes difﬁcult to extrapolate to the macro-
scopic level to explain synaptic events. Because of the
ensemble of events and frequency of activation of
AChR in the NMJ, single-channel studies may not be a
reliable method for determining the effect of these
AChR channel mutations on synaptic transmission.
Using whole-cell patch-clamp technique, we studied
the macroscopic properties of mutant and wild-type
AChRs expressed in HEK293 cells. We characterized
calcium permeability, desensitization rate, and chan-
nel open time. Evidence has suggested that variation
in several of these parameters can profoundly alter
AChR function. For example, mutations in the neuro-
nal nicotinic AChR in nocturnal frontal lobe epilepsy
lead to a decrease in Ca
2+ permeability and overactive
presynaptic terminals in inhibitory neurons (Kuryatov
et al., 1997). Also in both the congenital slow- and fast-
channel syndromes changes in the rates of desensitiza-
tion are believed to be partially responsible for both
impaired neuromuscular transmission and progressive
muscle atrophy (Bhattacharyya et al., 1997; Milone
et al., 1997; Sine et al., 1995). Finally, differences in
the decay time of macroscopic postsynaptic currents
observed in this syndrome may explain in part the dif-
ferent levels of disease severity in SCS, presumably by
through different degrees of cation overload.
In this study, we combined whole-cell patch clamp
and fast-step ligand perfusion techniques to character-
ize for the ﬁrst time a panel of AChR mutants associ-
ated with the SCS. We found, as expected, that SCS
AChR macroscopic decay currents are signiﬁcantly
slower than WT. Moreover, we found that a signiﬁcant
number of SCS mutations desensitize faster than WT
receptors. Finally, using ion substitution experiments,
we showed that Ca
2+ permeability does not, with one
exception, vary signiﬁcantly for most SCS mutants.
These results improve the understanding of the man-
ner in which the different SCS AChR mutations can al-
ter different kinetic parameters of these receptors in a
macroscopic setting. They suggest that no single
change in channel property provides direct correlation
with disease severity. Rather, the impairment in neu-
romuscular transmission and the different phenotypes
observed in this syndrome are most likely related to a
combination of effects on channel behavior ranging
from enhanced desensitization to prolonged macro-
scopic postsynaptic currents.
MATERIALS AND METHODS
Cell culture and transfection
The SCS mutations were generated in mouse nico-
tinic AChR muscle subunits cDNAs cloned into the
vector pcDNA/3 using site-directed mutagenesis
(Quick-change, Strategene, La Jolla, CA). The muta-
tion was conﬁrmed by dideoxy nucleotide sequence
analysis of the entire cDNA. For reversal potential
studies, human embryonic kidney 293 (HEK293, Gibco
BRL, Carlsbad, CA) cells were maintained in culture
at 378C, 5% CO2 in DMEM containing 10% FBS, 0.05
mg/ml Gentamicin (Gibco BRL, Carlsbad, CA). Cells
were transfected at *50% conﬂuency using the Effec-
tene transfection reagent (Quiagen, Valencia, CA). For
a 25-ml ﬂask, a total amount of 1 mg of DNA was used,
the transfection mix was composed of a ratio of
2a:b:e:d subunits. Cells expressing mature receptors
were selected 36–48 h after transfection by using mag-
netic beads (Dynal Biotech, Lake Success, NY) coated
with the mAb35 antibody (Tzartos and Lindstrom,
1980). Cells were replated into 60-mm petri dishes and
recordings were performed 18–24 h after replating.
Calcium permeability
Recordings from HEK293 cells were obtained in
whole cell conﬁguration with an Axoclamp 200B am-
pliﬁer and digitized through a Digidata 1320A (Axon
Instruments, Sunnyvale, CA) at 22–238C. The resis-
tance of the patch electrodes was between 2–4 MO.
The electrode solution was composed of 145 mM CsCl,
10 mM Hepes, and 5 mM 1,2-bis(2-aminophenoxy)-
ethane-N,N,N0,N0-tetraacetate (pH 7.3). Recordings
Fig. 1. Schematic diagram of slow-channel congenital myas-
thenic syndrome mutations explored in this study.
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mM CsCl, 1 mM CaCl2, and 10 mM HEPES (pH 7.3).
To determine the reversal potential of the AChRs volt-
age ramp protocols were applied while a fast step per-
fusion system (Warner Instruments, Hamden, CT)
applied an extracellular solution containing 100 mM
ACh. This protocol was succeeded by repeating the
ramp protocol with a solution containing 100 mM ACh.
The data were acquired using pClamp 8 software
(Axon Instruments) in a Pentium III personal com-
puter. The value of the reversal potential was deter-
mined for the different mutations at 1 and 10 mM
CaCl2. The calcium permeability was determined by
using an extended GHK equation used to calculate the
relative ion permeabilities with respect to Cs
+ (Castro
and Albuquerque, 1995):
PCa
PCs
¼
½Csþ Oð1   eVrevF=RTÞ
4½Ca2þ
1 OeVrevF=RTð1 þ eVrev1F=RTÞ
 1
  4½Ca2þ
10 Oð1 þ eVrev10F=RTÞ
 1
Permeability calculations were made using the
Mathematica 4.1 (Wolfram Research, Champaign, IL)
software. Statistical analyses of these results were
made using the StatView (SAS institute Inc, Cary, NC)
software package.
Desensitization
HEK293 cells were patch clamped in whole cell con-
ﬁguration in an extracellular solution composed of
37 mM NaCl, 2 mM CaCl2, 10 mM HEPES, 1 mM
MgCl2, and 10 mM glucose (pH 7.4) and pipette solu-
tion composed of 110 mM CsCl, 5 mM MgATP, 14 mM
EGTA, 20 mM HEPES, and 20 mM triethylamine (pH
7.2). Afterwards, cells were stimulated ﬁve times for
500 ms every second with 100 mM ACh. The percent-
age decrease between the ﬁrst depolarization and last
from cells that showed similar amplitudes to the ones
observed in cells expressing WT receptors (*10 nA)
was calculated. In addition, only cells bound to 3–5
mAb35 coated beads were used.
Decay currents
Cells were clamped using the extracellular and pip-
ette solutions used in the desensitization experiments.
Nondesensitizing concentrations of ACh (1 mM) were
applied with the fast step perfusion system while
applying the voltage-jump protocol showed in Figure 2.
To calculate the decay time, a second-term exponential
approximation was calculated by pClamp 8 software
package (Axon Instruments).
RESULTS
Slower macroscopic nicotinic decay
currents contribute to the SCS
In the intact NMJ, the mean time that two ACh mole-
cules remain bound to the postsynaptic nicotinic recep-
tors determines the decay time constant of the postsy-
naptic AChR, because diffusion and hydrolysis by ace-
tylcholinesterase removes free ACh from the synaptic
cleft rapidly (Anderson and Stevens, 1973; Katz and
Miledi, 1973; Magleby and Stevens, 1972). To roughly
estimate the current decay times of the SCS mutants,
we expressed the receptors in HEK293 cells and acti-
vated them with a relatively low concentration of ace-
tylcholine (1 mM). To obtain these decay currents, we
used a protocol based on voltage-jump relaxation stud-
ies, in which, during continuous AChR activation, the
cell receives a brief depolarizing stimulus followed by
negative hyperpolarization (Figl et al., 1996). The sec-
ond-term exponential approximation obtained from the
decay phase of these currents t is comparable with the
burst duration recorded at the single-channel level
(Auerbach et al., 1983; Figl et al., 1996). Although we
found difﬁcult to correlate the t of these currents with
previously reported values for the duration of single
channel bursts, this technique provided us with a rough
estimate for the duration of macroscopic currents in a
nondesensitizing environment. Under these conditions,
macroscopic decay currents in HEK293 cells should
resemble those of miniature endplate currents.
First, we looked at the SCS ligand binding site muta-
tions aG153S and aV156M. We found that both aG153S
(708.3 6 47.6 ms, n ¼ 10) and aV156M (1079.6 6 92.2 ms,
n ¼ 10) lead to a large increase of the decay time of the ac-
etylcholine induced currents (Fig. 2) when compared with
WT (352.5 6 7.2 ms, n ¼ 10). In addition, we studied the
decay currents of mutations in both the M1 and M2
domains of the AChRs. Our data demonstrate that, except
for the dS268F and aT254I mutations, SCS mutations sig-
niﬁcantly increase the decay time (bV229F 564.1 6
20.0 ms, n ¼ 10; aT254I 325.6 6 23.0 ms, n ¼ 10; bL262M
830.0 6 30.0 ms, n ¼ 10; eT264P 951.1 6 95.6 ms, n ¼ 10;
bV266A 498.2 6 20.0 ms, n ¼ 10; dS268F 327.6 6
15.0 ms, n ¼ 10; and eL269F 840.1 6 20.2 ms, n ¼ 10).
These ﬁndings conﬁrm that the burst activity of mutated
SCS AChR have a signiﬁcant impact on the decay phase
of macroscopic ACh induced currents.
M2 domain mutations desensitize when
subject to fast acetylcholine stimulation
To characterize the sustained responses of mutant
AChRs macroscopically, we devised an approach that
employs brief pulses of ACh to HEK293 cells expressing
mutant AChRs. We systematically stimulated HEK293
cells expressing each of 12 distinct SCS mutations with
500 ms pulses of 100 mM acetylcholine and determined
the changes in the amplitude of peak currents between
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2002). Several of the M2 domain mutations exhibited
macroscopic desensitization when compared with WT
(35% 6 3%, n ¼ 4). The results obtained from cells ex-
pressing aV249F (94% 6 1%, n ¼ 4) agree qualitatively
with studies cited previously (Milone et al., 1997). In
addition, the M2 mutations (aT254I 85% 6 2%, n ¼ 3;
bL262M 86% 6 3%, n ¼ 3; bV266A 87% 6 1%, n ¼ 4;
dS268F 50% 6 3%, n ¼ 3; eV265A 79% 6 3%, n ¼ 3; and
eL269F 65% 6 3%, n ¼ 3) desensitized nearly as rapidly
(Fig. 3). Other mutants, such as eT264P (32% 6 3%, n ¼
3) and bV229F (33% 6 7%, n ¼ 4), behaved exactly as
W TA C h R si nt h i sp a r a d i g m .M u t a t i o n sa tt h el i g a n d
binding site (aG153S 85% 6 6%, n ¼ 3a n daV156M
78% 6 2%, n ¼ 3) had the tendency to desensitize nearly
as fast as M2 mutations. In addition, after the removal
of the ligand, the time of recovery to resting potential
w a sl o n g e rt h a nt h a to b s e r v e di nW Ta n do t h e rS C S
channels (data not shown). This suggests that the
enhanced desensitization may be due to increased afﬁn-
ity (Croxen et al., 1997) between the ligand and the
ligand binding site in these AChR mutations.
Ca
2+ permeability remains mostly
unchanged in SCS mutations
Histochemical studies of muscle biopsy material ob-
tained from patients and a transgenic mouse model of
Fig. 2. Macroscopic decay currents of slow-channel syndrome
(SCS) are signiﬁcantly slowed by most SCS mutations. Decay cur-
rent of human embryonic kidney cells (HEK293) expressing acetyl-
choline (1 mM) activated AChR were studied by applying a brief
hyperpolarizing stimulus (50 mV) followed by a series of voltage
steps. All of the ligand binding site and ﬁrst transmembrane do-
main (M1) mutations exhibit long decay times (aG153S 708.3 6
47.6 ms, aV156M 1079.6 6 92.2 ms, bV229F 564.1 6 20.0 ms, n ¼
10) when compared with WT receptors (352.5 6 7.2 ms, n ¼ 10). All
but two of the pore-forming second transmembrane domain (M2)
mutations have slowed decay currents (bL262M 830.0 6 30.0 ms,
eT264P 951.1 6 95.6 ms, bV266A 498.2.7 6 20.0 ms, eL269F 840.1
6 20.2 ms, n ¼ 10), although aT254I and dS268F displayed currents
that were not signiﬁcantly different from the ones observed in nor-
mal receptors (aT254I 325.6 6 23.0 ms, and dS268F 327.6 6 15.0
ms, n ¼ 10).
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endplate region. Using ionic substitution methods in
voltage clamped HEK293 cells, we tested whether SCS
mutations differed in their effect on calcium perme-
ability. We expressed 12 different SCS AChR muta-
tions in HEK293 cells and determined the reversal
potentials of the activated receptors in both solutions
containing 1 and 10 mM CaCl2.B ya p p l y i n gt h em e a -
sured reversal potentials in the extended version of the
GHK equation described in the methods section, we cal-
culated the relative Ca
2+ permeability of receptors ex-
pressing each mutation (Fig. 4). The permeability value
obtained of 0.44 6 0.11, n ¼ 5, PCa
2+/PCs
+ in WT recep-
tors matches the previously reported estimates (Castro
and Albuquerque, 1995; Cens et al., 1997; Ragozzino
et al., 1998). Surprisingly, no spontaneous M2 mutation
had any signiﬁcant effect on Ca
2+ permeability com-
pared with WT AChRs (aT254I 0.63 6 0.20, n ¼ 3
PCa
2+/PCs
+; bL262M 1.00 6 0.50, n ¼ 3 PCa
2+/PCs
+;
eV265F 0.32 6 0.02, n ¼ 3 PCa
2+/PCs
+; bV266M 0.72 6
0.14, n ¼ 3 PCa
2+/PCs
+; dS268F 0.60 6 0.20, n ¼ 4
PCa
2+/PCs
+;a n deL269F 0.78 6 0.12, n ¼ 3 PCa
2+/
PCs
+). We were not able to study the mutant AChR,
aV249F, because of extremely fast desensitization. How-
ever, these ﬁndings suggest that the spontaneous mis-
sense mutations in the pore forming domain that affect
gating kinetics and desensitization in SCS do not alter
Ca
2+ selectivity in these receptors. Similarly, estimates
of Ca
2+ permeability for the ligand binding site muta-
tions aG153S (0.87 6 0.18, n ¼ 4 PCa
2+/PCs
+)a n d
aV156M (0.99 6 0.28, n ¼ 3 PCa
2+/PCs
+) also revealed
no signiﬁcant differences in the permeability of these
receptors from WT, supporting the notion that these res-
idues are not involved in the movement of this cation.
Finally, we studied permeability in SCS mutations
in the ﬁrst transmembrane domain that forms the
outer part of the pore, remote from the channel gate.
As with the other SCS mutations, neither aN217K
(0.37 6 0.11, n ¼ 6 PCa
2+/PCs
+) nor eL221F (0.37 6
0.12, n ¼ 6 PCa
2+/PCs
+) had signiﬁcant effects on Ca
2+
permeability. However, the adjacent mutation, bV229F,
signiﬁcantly increased Ca
2+ permeability. The value of
1.6 6 0.16, n ¼ 6 PCa
2+/PCs
+ showed a four-fold in-
crease in the amount of calcium that is moved through
the pore. This somewhat surprising result suggests that
this residue might be near a region in the M1 domain
that contributes to determining the ion selectivity of the
pore. The results obtained demonstrated that, with the
exception of bV229F, mutations in SCS do not alter the
Ca
2+ permeability of AChR.
DISCUSSION
When muscle from human biopsies and murine SCS
models are stained using glyoxal-bis-2-hydroxy-anil, a
histochemical dye that detects free calcium ion in the
millimolar range, intense labeling appears around the
NMJ region (Gomez et al., 2002a; Ohno et al., 1995a;
Vohra et al., 2004). The accumulation of free Ca
2+ ions
at postsynaptic sites suggests that this cation may play
a major role in the degenerative process observed in
SCS muscle endplates. It has been suggested that the
slow kinetics of endplate currents inﬂuence the overall
quantity of cations moving to the sarcoplasm, leading
Fig. 3. SCS mutations have a reduced rate of recovery from
desensitization. HEK293 cells expressing the different AChR were
stimulated ﬁve times with acetylcholine (500 mM) for 500 ms every
second. The rate of recovery based on the amplitude between the ﬁrst
stimulus and the last is expressed as % desensitization. The vast ma-
jority of SCS mutations studied (aG153S 85% 6 6%, aV156M 78% 6
2%, aT254I 85% 6 2%, bL262M 86% 6 3%, bV266A 87% 6 1%,
dS268F 50% 6 3% (n ¼ 3), eV265A 79% 6 3% (n ¼ 3), and eL269F
65% 6 3% (n ¼ 3), P < 0.01, n   3) recovered from desensitization
much more slowly than WT receptors (35% 6 3%, n ¼ 4). Only the
mutants eT264P (32% 6 3%, n ¼ 3) and bV229F (33% 6 7%, n ¼ 4)
had rates of recovery that were similar to WT AChR.
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2+ deposits (Gomez et al., 1997,
2002a). The role of the mutant receptors and choliner-
gic activity in this process in SCS is further supported
by the dependence of this process on synaptic activity.
Exercise increases the number and intensity of gly-
oxal-bis-2-hydroxy-anil stained endplates (Gomez
et al., 2002a). Axotomy of the motor nerve leads to the
complete disappearance of the accumulated of calcium
in the subsynaptic area of the muscle ﬁbers (Groshong
et al., submitted).
Changes in the permeation properties of different
ligand gated channels including AChR have also been
linked to different models of Ca
2+ excitotoxicity (Glaz-
ner et al., 2000; Kuryatov et al., 1997; Sattler and
Tymianski, 2001). Previous studies associated calcium
overload with changes in the Ca
2+ permeability of the
mutated receptor, although the correlation was only
found with synthetic M2 mutations. The number of
naturally occurring mutations studied was very lim-
ited and increments in Ca
2+ permeation were not
Fig. 4. Changes in calcium permeability cannot account for
pathogenicity in SCS. Ca
2+/Cs
+ permeability (PCa
2+/PCs
+) for both
WT and SCS AChR was determined by recording the reversal poten-
tials at two different concentrations of extracellular Ca
2+ (A), and
solving the value from a modiﬁed Goldman–Hodgkin–Katz equa-
tion. PCa
2+/PCs
+ of ligand binding site mutations (aG153S 0.87 6
0.18 PCa
2+/PCs
+, and aV156M 0.99 6 0.28 PCa
2+/PCs
+, n   3) was
slightly but not signiﬁcantly higher (B) than the permeability value
observed in WT receptors (0.44 6 0.11, n ¼ 5 PCa
2+/PCs
+). Although
most M1 mutations had permeability values similar to the ones
observed in WT AChR (aN217K 0.37 6 0.05, n ¼ 6 PCa
2+/PCs
+, and
eL221F 0.37 6 0.05, n ¼ 6 PCa
2+/PCs
+), the b subunit mutation
bV229F (1.6 6 0.16, n ¼ 6 PCa
2+/PCs
+) had a permeability value
three times larger than normal receptors (C). Finally, there were no
signiﬁcant differences between most M2 SCS mutations (aT254I
0.63 6 0.20 PCa
2+/PCs
+, bL262M 1.00 6 0.50 PCa
2+/PCs
+, eV265F
0.32 6 0.02 PCa
2+/PCs
+, bV266M 0.72 6 014 PCa
2+/PCs
+, dS268F
0.60 6 0.20 PCa
2+/PCs
+, and eL269F 0.78 6 0.12 PCa
2+/PCs
+, n  
3) and WT receptors despite their association with severe disease se-
verity (D).
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subunit combinations, most notably the developmental
switch from d to e, can lead to changes in Ca
2+ perme-
ability of the AChR. This change is believed to be im-
portant for regulation of gene expression (Castro and
Albuquerque, 1995; Dani, 1993; Witzemann et al.,
1987). Most neuronal nicotinic receptor subtypes are
more permeable to Ca
2+ than muscle receptors.
Changes in Ca
2+ permeability due to mutations in the
vicinity of the M2 domain of neuronal AChRs are
believed to be responsible for the molecular phenotype
of the frontal lobe nocturnal epilepsy (AFLNE) (Ber-
trand et al., 1998; Figl et al., 1998; Kuryatov et al.,
1997). After an extensive study of a large panel of SCS
mutations, we found little differences in the Ca
2+ per-
meability of these mutated channels, except for the
bV229F mutation. In this M1 mutation, we observed
an almost three-fold increase in Ca
2+ permeability
(Table I). This change in AChR permeability is not as
profound than the up to 20-fold increase observed in
one of the AFLNE mutations (Ragozzino et al., 1998).
However, given that individuals in this SCS kindred
suffered from a very mild form of disease, it is likely
that differences in channel divalent cation permeation
alone do not play a prominent role in the pathogenesis
of SCS.
From a structural standpoint, the changes in the
Ca
2+ permeability caused by the M1 mutation, bV229F,
support the notion that the ion selectivity and inward
rectiﬁcation properties of AChRs are determined by a
small number of residues in the rings ﬂanking the pore,
and not amino acids located nearby the hydrophobic
gate (Galzi et al., 1992; Gunthorpe and Lummis, 2001;
Haghighi and Cooper, 2000). The lack of effect of the
similar mutation, eV265F, on permeability suggests
that polar residues distal to the pore-forming region can
contribute to the movement of this cation across from
the extracellular space into the channel pore. This ﬁnd-
ing further expands our understanding of the M1 do-
main and the different roles it plays during channel
activation.
AChR desensitization, a phenomenon ﬁrst studied in
frog NMJ, is responsible for the reduction in the size of
endplate currents after repetitive stimulus of the mus-
cle AChR in the absence of acetylcholinesterase (Bhat-
tacharyya et al., 1997; Elenes and Auerbach, 2002;
Jones and Westbrook, 1996; Magleby and Pallotta,
1981). Although little is known about the molecular
mechanisms of desensitization, a two-gate mechanism
comparable with the one observed in other ion chan-
nels has been suggested (Auerbach and Akk, 1998).
Different factors can inﬂuence how fast AChRs desen-
sitize, including the duration of ligand exposure and
conformational changes in the receptor protein struc-
ture that alter the stability of the different desensi-
tized states (Auerbach and Akk, 1998; Elenes and
Auerbach, 2002). Increased desensitization of the
T
A
B
L
E
I
.
C
l
i
n
i
c
a
l
c
o
r
r
e
l
a
t
i
o
n
c
o
m
p
a
r
i
n
g
e
l
e
c
t
r
o
p
h
y
s
i
o
l
o
g
i
c
a
l
p
r
o
p
e
r
t
i
e
s
o
f
t
h
e
m
u
t
a
t
i
o
n
s
a
n
d
d
i
f
f
e
r
e
n
t
p
a
t
h
o
l
o
g
i
c
a
l
f
e
a
t
u
r
e
s
a
G
1
5
3
S
b
V
1
5
6
M
a
N
2
1
7
K
b
V
2
2
9
F
e
L
2
2
1
F
a
V
2
4
9
F
a
T
2
5
4
I
b
L
2
6
2
M
b
V
2
6
6
A
b
V
2
6
6
M
d
S
2
6
8
F
e
T
2
6
4
P
e
V
2
6
5
A
e
L
2
6
9
F
D
i
s
e
a
s
e
s
e
v
e
r
i
t
y
M
i
l
d
M
i
l
d
M
i
l
d
M
i
l
d
M
i
l
d
S
e
v
e
r
e
M
i
l
d
S
e
v
e
r
e
S
e
v
e
r
e
S
e
v
e
r
e
S
e
v
e
r
e
S
e
v
e
r
e
S
e
v
e
r
e
S
e
v
e
r
e
A
g
e
o
f
o
n
s
e
t
i
n
f
a
n
t
–
5
7
1
4
8
–
5
7
1
8
–
3
0
1
7
–
4
0
i
n
f
a
n
t
1
6
i
n
f
a
n
t
i
n
f
a
n
t
c
h
i
l
d
h
o
o
d
i
n
f
a
n
t
i
n
f
a
n
t
i
n
f
a
n
t
i
n
f
a
n
t
C
a
2
+
p
e
r
m
e
a
b
i
l
i
t
y
+
+
+
+
+
+
n
/
a
+
+
+
+
+
+
+
+
D
e
s
e
n
s
i
t
i
z
a
t
i
o
n
(
%
)
+
+
+
+
n
/
a
+
n
/
a
+
+
+
+
+
+
+
+
n
/
a
+
+
+
+
+
+
+
t
(
m
s
)
+
+
+
+
n
/
a
+
+
n
/
a
n
/
a
+
+
+
+
+
n
/
a
+
+
+
n
/
a
+
+
C
l
i
n
i
c
a
l
c
o
r
r
e
l
a
t
i
o
n
l
o
w
l
o
w
g
o
o
d
l
o
w
g
o
o
d
g
o
o
d
m
e
d
g
o
o
d
g
o
o
d
l
o
w
l
o
w
m
e
d
m
e
d
g
o
o
d
+
V
a
l
u
e
s
n
o
t
s
i
g
n
i
ﬁ
c
a
n
t
l
y
d
i
f
f
e
r
e
n
t
w
h
e
n
c
o
m
p
a
r
e
d
t
o
W
T
.
+
+
V
a
l
u
e
s
s
i
g
n
i
ﬁ
c
a
n
t
l
y
d
i
f
f
e
r
e
n
t
w
h
e
n
c
o
m
p
a
r
e
d
t
o
W
T
.
447 MACROSCOPIC PROPERTIES OF SCS MUTATIONS
Synapse DOI 10.1002/synmutated receptors during synaptic activity could have
profound effects on the ability of the muscle ﬁber to
reach its depolarizing threshold. Paradoxically, this
may also actually diminish the effect of a prolonged
channel opening on cation overload. Enhanced desen-
sitization has only been documented for aV249F
(Milone et al., 1997). The study of the desensitization
rates of AChRs at the macroscopic level provided us
with useful information about how these receptors
react to tetanic ligand stimulation with acetylcholine,
especially over short time scales. Fast desensitization
of receptors could be partially responsible for the
weakness phenotype observed in many of the SCS
patients, as it is in at least one murine model of SCS
(Bhattacharyya et al., 1997; Milone et al., 1997).
Our studies showed that a large number of muta-
tions in the M2 domain exhibit signiﬁcant changes in
the rate of desensitization when studied with this
protocol. This observation suggests that mutations
around the gate region of the receptor are capable of
shifting the dynamic equilibrium of the channel be-
tween the open state and desensitized state. There is a
modest correlation between these mutations and
patients who suffer from severe muscle weakness and
fatigue (Table I). The desensitizing feature could play
a major role during the early stages of the disease or
patients with early onset of disease (Table I). Reduced
ability of mutated receptors to respond to synaptic ac-
tivity, due to enhanced desensitization, could have a
profound effect on the ability of the muscle to reach its
depolarizing threshold. The inability of AChRs to
recover from their desensitized state, especially during
periods of repeated synaptic activity, could lead to se-
rial and progressive decrease of AChR currents, and
reduction of the safety factor of neuromuscular trans-
mission. Alternatively, desensitization could, in theory,
protect muscle cells from the prolonged opening of the
postsynaptic AChRs. Until individual SCS mutants
are tested that differ in only single properties this
question cannot be fully resolved.
Finally, it has been suggested that the slowed
kinetics of endplate currents might inﬂuence the over-
all quantity of cations moving to the sarcoplasm. The
electrophysiological hallmark of SCS is slow decay of
endplate currents. Although it is known that the
altered gating of the mutated channels inﬂuences the
endplate currents, the effect of a panel of mutations on
the macroscopic decay time of the mutated AChR cur-
rents has not been compared until now. The results
obtained in this experiment suggest that the prolonged
decay currents exhibited by SCS mutations may be
partially responsible for the cation overload observed
in this syndrome. In addition, slowed currents lead to
prolonged depolarization of the endplate region which
may disturb voltage dependent binding and gating of
AChRs (Auerbach et al., 1996). Curiously, relaxation
current experiments for mutations aT254I and dS268F
have values that are similar to the ones observed in
WT AChR expressing HEK293 cells. These ﬁndings
contradict results obtained from single channel patch-
clamp and muscle electrophysiology studies of these
SCS mutations (Croxen et al., 1997; Gomez et al.,
2002b). Anomalies in voltage-jump relaxation experi-
ments and their interpretation have been previously
reported (Figl et al., 1996). The relation between the
rate opening constant and the steady state response,
and how these values change in relation to each other
when studied under this experimental paradigm,
remains unclear. We have shown that, unlike other
SCS mutations, the rate of opening of dS268F is
greatly decreased (Gomez et al., 2002b). This change,
and perhaps the behavior of these mutations under dif-
ferent concentrations of ligand, could explain the rela-
tively fast t observed in these experiments.
This is the ﬁrst time different parameters of such
large array of SCS have been compared side by side.
The combined study of these parameters demonstrated
that there is a strong trend between both the decay
time of nicotinic AChR currents, the rate of desensiti-
zation and the severity of the disease, but, as in other
syndromes, no single change in SCS AChR function
that can serve as a universal predictor for disease se-
verity. Nevertheless, these studies provide evidence
that, unlike previously thought (Gomez et al., 2002a)
Ca
2+ permeability does not play a role in this disorder.
Second, it gives us a better understanding of the na-
ture of different kinetic parameters of these mutated
channels.
This study conﬁrms that several AChR channel
properties that affect macroscopic currents are altered
in SCS. Such changes may greatly alter synaptic
transmission, but because each SCS mutation exhibits
changes in several properties, the relative contribution
of each change to disease is difﬁcult to estimate.
Nevertheless, these results demonstrate the utility of
studying mutations in macroscopic conﬁguration and
provide a platform for future comparisons of additional
SCS mutations.
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